Skip to main content

Regeneron Pharmaceuticals, Inc 10-Q for FY2021 Q2

Regeneron Pharmaceuticals, Inc. (REGN)

10-Q 2021-08-05 For: 2021-06-30
View Original
Added on April 08, 2026

About this 10-Q

Regeneron Pharmaceuticals, Inc filed this 10-Q on August 5, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).

Headline figures

Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$5.14B
up 163.2% from $1.95B a year earlier
Net income
$3.1B
up 245.4% from net income of $897.3M a year earlier
Diluted EPS
$27.97
up 267.5% from $7.61 a year earlier